PANCREATIC CANCER METASTATIC
Clinical trials for PANCREATIC CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC CANCER METASTATIC trials appear
Sign up with your email to follow new studies for PANCREATIC CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells Tailor-Made to attack pancreatic cancer enter first human test
Disease control Not yet recruitingThis early-stage trial tests a new therapy called MT-601, which uses a patient's own immune T-cells trained to recognize multiple cancer-related targets. It is for people with advanced pancreatic cancer that cannot be removed by surgery or has spread. The study will check safety …
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1 • Sponsor: Marker Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug called IBI363 combined with chemotherapy for people with advanced pancreatic cancer that has worsened after first treatment. About 48 patients will receive the combination to see if it is safe and helps control the cancer. The goal is to slow disease p…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE1, PHASE2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental vaccine takes on tough pancreatic cancer
Disease control Not yet recruitingThis early-phase trial will test a new tumor vaccine (SapDM275) combined with standard chemotherapy in 13 people with metastatic pancreatic cancer who have not had prior treatment. The vaccine aims to help the immune system attack cancer cells. The main goal is to check safety, b…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: EARLY_PHASE1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Immunotherapy injected directly into fluid cavities shows promise for pancreatic cancer
Disease control Not yet recruitingThis phase 2 trial tests whether putting an immunotherapy drug called adebrelimab directly into the chest or belly can help control cancer-related fluid buildup in people with advanced pancreatic cancer. About 20 participants will receive the drug along with standard care. The go…
Matched conditions: PANCREATIC CANCER METASTATIC
Phase: PHASE2 • Sponsor: Sizhen Wang • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New study tests if tumor genes and organoids can outsmart pancreatic cancer
Knowledge-focused Not yet recruitingThis observational study will enroll 185 people with metastatic pancreatic cancer to see if analyzing tumor genes and lab-grown organoids can predict which standard chemotherapy regimens work best. Researchers will compare predicted drug sensitivity to actual patient outcomes. Th…
Matched conditions: PANCREATIC CANCER METASTATIC
Sponsor: Prof. Dr. med. Dres. h.c. Jan Schmidt, MME • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC